Oncor Inc. of Gaithersburg, Md., said it formed an exclusivemarketing agreement with Amersham Buchler ofBraunschweig, Germany, for the sale of Oncor's products incertain European countries.
According to Steven Turner, Oncor's chief executive officer,under the terms of the agreement Amersham will receiveexclusive distribution rights in Germany, Austria, Switzerlandand some Eastern European countries in exchange for aguarantee that Amersham achieves a minimum level of sales ofOncor's DNA probes and reagent kits for cancer and genetictesting. Oncor sells the kits itself in the U.S.
Oncor's product sales for the year to date are $4 million, up 70percent from last year, with 20 percent drawn frominternational sources. -- Michelle Slade
(c) 1997 American Health Consultants. All rights reserved.